$ICCC News

ZTS vs. ICCC: Which Animal Health Stock Is the Better Investment Bet?

ImmuCell Announces a 46% Increase in Product Sales in Quarter Three of 2026, Based on Preliminary, Unaudited Sales Results

ImmuCell Sees Q3 Sales $8.000M

ImmuCell Reports Q3 Preliminary Sales Of $8M, Up 46% YoY

ImmuCell Stock Falls 8.8% Despite Y/Y Earnings & Sales Growth in Q2

ImmuCell (ICCC) Q2 2026 Earnings Call Transcript

ImmuCell Corp (ICCC) (Q2 2026) Earnings Call Highlights: Record Net Income and Market Share ...

ImmuCell Corporation 2026 Q2 - Results - Earnings Call Presentation

ImmuCell Corporation (ICCC) Q2 2026 Earnings Call Transcript

ImmuCell Q2 Earnings Call Highlights

ImmuCell Corporation Q2 2026 Earnings Call Summary

ImmuCell Reports Q2 2026 Results: Full Earnings Call Transcript

ImmuCell Announces Unaudited Financial Results for the Quarter Ended June 30, 2026

ImmuCell Q2 EPS $0.20 Up From $0.06 YoY, Sales $7.186M Up From $6.445M YoY

ImmuCell to Announce Unaudited Financial Results for the Quarter Ended June 30, 2026

ImmuCell: First Defense With Better Execution

ImmuCell Posts Strong Preliminary Q2 Sales on U.S. Demand

ImmuCell Announces a 12% Increase in Product Sales in Q2 of 2026 and a 21% Increase in the First Six Months of 2026, Based on Preliminary, Unaudited Sales Results

ImmuCell Q2 Total Product Sales Rises 12%

ICCC's Valuation Remains Premium: Is it Worth Overpaying for?